Approved for Canada

Astrazeneca logo

SAPHNELO LQD 300MG VI 1X2.0ML CA

Product Information for Healthcare Professionals

IMPORTANT NOTES :

  • The information available on this Website is the most recently approved version in your country.
  • Where information available on paper leaflet inside the pack might not be the most recently approved version.

Continue Downloading?

The Content in this document is only valid on the date that you download it. We may change the content in future.